New product [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 16:54 (422 d 02:17 ago) – Posting: # 21257
Views: 3,341

Dear SKM,

» Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?

Well, you are giving all the arguments yourself: up to now the two active substances are only marketed as separate formulations. You will be mixing them into one new formulation, which has never been tested or marketed before. Sorry, but I can't explain more.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,445 posts in 4,482 threads, 1,511 registered users;
online 18 (0 registered, 18 guests [including 2 identified bots]).
Forum time: Friday 19:12 UTC (Europe/Vienna)

The plural of anecdote is not data.    Roger Brinner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5